Tuesday, March 17, 2026

New Hope for Alcohol-Related Liver Disease: GLP-1 Drugs Show Promise

Research shows that GLP-1 receptor agonists, like Wegovy, may help combat alcohol-related liver disease, reducing liver cancer risk.

North Korea’s 2026 Election: What to Expect from the Supreme People’s Assembly Vote?

North Korea will hold its Supreme People's Assembly elections on March 15, marking a significant political event after seven years.

North Korea’s New Car Ownership Law: A Reaction to Rising Private Vehicle Numbers?

North Korea's rise in car ownership is misinterpreted; it's a formalization of existing private vehicle use, not solely due to new laws.

Tag: Medipost

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us